LIPOCINE INC. Litigation Settlement, Expense
LIPOCINE INC. (LPCN) reported Litigation Settlement, Expense of $4.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2022-03-09
- LIPOCINE INC. litigation settlement, expense for the quarter ending 2021-12-31 was $0.00.
- LIPOCINE INC. litigation settlement, expense for the quarter ending 2021-09-30 was $0.00.
- LIPOCINE INC. litigation settlement, expense for the quarter ending 2021-06-30 was $4.00M.
- LIPOCINE INC. litigation settlement, expense for the quarter ending 2021-03-31 was $0.00.
- LIPOCINE INC. litigation settlement, expense for fiscal 2021 was $4.00M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $0.00 derived: sum of 2 quarters · filed 2022-03-09 | $4.00M derived: sum of 3 quarters · filed 2022-03-09 | $4.00M 10-K · filed 2022-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.00M derived: sum of 2 quarters · filed 2021-11-10 | $4.00M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $4.00M 10-Q · filed 2021-08-05 | $4.00M 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |